AtaiBeckley (ATAI) Short term Debt (2021 - 2026)

AtaiBeckley's (ATAI) quarterly Short term Debt came in at $310000.0 in Q1 2026, up 14.39% quarter-over-quarter from $271000.0 in Q4 2025.

AtaiBeckley (ATAI) Short term Debt (2021 - 2026) Analysis & Trends

AtaiBeckley's Short term Debt history runs 3 years deep, the most recent figure standing at $310000.0 for Q1 2026.

  • On a quarterly basis, Short term Debt changed N/A year-over-year to $310000.0 in Q1 2026; TTM through Mar 2026 was $310000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $271000.0, down 95.75% from the prior year.
  • Short term Debt rose to $310000.0 in Q1 2026 per ATAI's latest filing, from $271000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $161.5 million in Q3 2022 to a low of $38000.0 in Q3 2021.
  • A 5-year average of $30.8 million and a median of $275000.0 in 2023 frame the typical range for Short term Debt.
  • Biggest YoY gain for Short term Debt was 95.75% in 2025; the steepest drop was 95.75% in 2025.
  • Year by year, Short term Debt stood at $6.4 million in 2024, then tumbled by 95.75% to $271000.0 in 2025, then increased by 14.39% to $310000.0 in 2026.
  • Per Business Quant, the three latest ATAI Short term Debt figures stand at $310000.0 (Q1 2026), $271000.0 (Q4 2025), and $6.4 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 AtaiBeckley 2.56 Bn 2.56 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 310,000.00
Dec 31, 2025 271,000.00
Sep 30, 2025 532,000.00
Mar 31, 2025 11.37 Mn
Dec 31, 2024 6.37 Mn
Dec 31, 2024 6.37 Mn
Sep 30, 2024 257,000.00
Jun 30, 2024 239,000.00
Mar 31, 2024 244,000.00
Dec 31, 2023 275,000.00
Sep 30, 2023 132.50 Mn
Jun 30, 2023 86.40 Mn
Sep 30, 2022 161.50 Mn
Dec 31, 2021 51,000.00
Sep 30, 2021 38,000.00
Jun 30, 2021 39,000.00